Stock listing
ABLD Stock Price, News, Filings & Events — Abl Diagnostics Sa
Selected listing: ABLD · EURONEXT · EUR · FR
This page tracks Abl Diagnostics Sa's ABLD:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABLD:EURONEXT. ABLD:EURONEXT is the stock-level entry point for investors researching Abl Diagnostics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abl Diagnostics SA is a public company traded under the ticker ABLD on the French market. With a market capitalization of approximately €42.8 million, the company focuses on developing innovative diagnostic solutions. Its commitment to advancing healthcare technology positions it as a notable player in the diagnostics sector.
- Ticker
- ABLD:EURONEXT
- Asset type
- Stock
- Market cap
- $44.9M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- EURONEXT
- Currency
- EUR
Abl Diagnostics Sa ABLD:EURONEXT stock context
This page tracks Abl Diagnostics Sa's ABLD:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABLD:EURONEXT. ABLD:EURONEXT is the stock-level entry point for investors researching Abl Diagnostics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Abl Diagnostics SA is a public company traded under the ticker ABLD on the French market. With a market capitalization of approximately €42.8 million, the company focuses on developing innovative diagnostic solutions. Its commitment to advancing healthcare technology positions it as a notable player in the diagnostics sector.
Latest news from Abl Diagnostics Sa
ABL Diagnostics Announces Availability of the Latest All Invest Securities Research Report
September 14, 2026
ABL Diagnostics (ABLD) Announces the Filing of a Takeover Bid for Integragen
September 11, 2026
ABL Diagnostics - TEXCELL Strengthens Its Position as an International Reference in Safety and Viral Clearance With a New Strategic Partn...
September 10, 2026
ABL Diagnostics Confirms Its Change of Scale in the First Half of 2026: Revenue up 90.0%, EBITDA Multiplied by More Than Four and Net Inc...
September 8, 2026
ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of...
August 27, 2026
Research Abl Diagnostics Sa
Abl Diagnostics Sa investor report
Review AI stock analysis and investor report context for ABLD:EURONEXT.
Abl Diagnostics Sa company profile
View the public company page for Abl Diagnostics Sa on 6ix.
Abl Diagnostics Sa news
Read company news and market updates connected to Abl Diagnostics Sa.
Abl Diagnostics Sa investor events
Find investor webinars, events, and replay context for Abl Diagnostics Sa.
Alternate listings
A3DL82:LSX
DE · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is ABLD:EURONEXT.
ABLDP:AQUISUK
GB · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is ABLD:EURONEXT.
ABLDP:AQUISEU
GB · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is ABLD:EURONEXT.
A3DL82:LS
DE · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is ABLD:EURONEXT.
9BK0:FWB
DE · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is ABLD:EURONEXT.
9BK0:SWB
DE · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is ABLD:EURONEXT.